1. Matrix Metalloproteinase-3 induces proteoglycan degradation in gouty arthritis model
   Le Shi et al, 2021, Gene CrossRef
2. Cannabinoid-based therapy as a future for joint degeneration. Focus on the role of CB2 receptor in the arthritis progression and pain: an updated review
   Marta Bryk et al, 2021, Pharmacological Reports CrossRef
3. Role of cannabinoid receptor 1 and the peroxisome proliferator-activated receptor α in mediating anti-nociceptive effects of synthetic cannabinoids and a cannabinoid-like compound
   Mohammad Alsalem et al, 2019, Inflammopharmacology CrossRef
4. EZH2 is associated with cartilage degeneration in osteoarthritis by promoting SDC1 expression via histone methylation of the microRNA-138 promoter
   Jian Wang et al, 2021, Laboratory Investigation CrossRef
5. Dose‐Dependent Cannabidiol‐Induced Elevation of Intracellular Calcium and Apoptosis in Human Articular Chondrocytes
   Martina Winklmayr et al, 2019, Journal of Orthopaedic Research CrossRef
6. HU308 Mitigates Osteoarthritis by Stimulating Sox9-Related Networks of Carbohydrate Metabolism
   Idan Carmon et al, 2020, Journal of Bone and Mineral Research CrossRef
7. Tendon Homeostasis: Overview
   Angela W. Ilaltdinov et al, 2020, Encyclopedia of Bone Biology CrossRef
8. Exosomal miR-9-5p secreted by bone marrow–derived mesenchymal stem cells alleviates osteoarthritis by inhibiting syndecan-1
   Zhe Jin et al, 2020, Cell and Tissue Research CrossRef
9. Cannabinoids in Autoimmune and Rheumatic Diseases
   Luca Navarini et al, 2019, Mosaic of Autoimmunity CrossRef
10. Cannabinoids for the treatment of rheumatic diseases — where do we stand?
    Daphna Katz-Talmor et al, 2018, Nature Reviews Rheumatology CrossRef
11. Medical cannabis and cannabinoids in rheumatology: where are we now?
    Piercarlo Sarzi-Puttini et al, 2019, Expert Review of Clinical Immunology CrossRef
12. Cannabis for Rheumatic Disease Pain: a Review of Current Literature
    William Benjamin Nowell et al, 2022, Current Rheumatology Reports CrossRef
13. The Current Evidence for Marijuana as Medical Treatment
    J. Stewart Buck et al, 2020, Journal of Bone and Joint Surgery CrossRef
14. Perceptions and Opinions on Cannabidiol in the Orthopaedic Sports Medicine Community
    Zachary I. Li et al, 2023, Orthopaedic Journal of Sports Medicine CrossRef
15. Selective CB2 inverse agonist JTE907 drives T cell differentiation towards a Treg cell phenotype and ameliorates inflammation in a mouse model of inflammatory bowel disease
    Marco Gentili et al, 2019, Pharmacological Research CrossRef
16. Knowledge and Opinion on Cannabinoids Among Orthopaedic Traumatologists
    Garwin Chin et al, 2021, JAAOS: Global Research and Reviews CrossRef
17. Protective effects of specific cannabinoid receptor 2 agonist GW405833 on concanavalin A-induced acute liver injury in mice
    Ze-bing Huang et al, 2019, Acta Pharmacologica Sinica CrossRef
18. In Vitro Effects of Low Doses of β-Caryophyllene, Ascorbic Acid and d-Glucosamine on Human Chondrocyte Viability and Inflammation
    Elena Mattiuzzo et al, 2021, Pharmaceuticals CrossRef
19. The Endogenous Cannabinoid System: A Budding Source of Targets for Treating Inflammatory and Neuropathic Pain
    Giulia Donvito et al, 2018, Neuropsychopharmacology CrossRef
20. Interleukin‐34 Reprograms Glycolytic and Osteoclastic Rheumatoid Arthritis Macrophages via Syndecan 1 and Macrophage Colony‐Stimulating Factor Receptor
    Katrien Van Raemdonck et al, 2021, Arthritis & Rheumatology CrossRef